Mechanisms of Fatigue in Liver Disorders
Fatigue in liver disease arises through multiple interconnected pathophysiological pathways involving metabolic dysfunction, systemic inflammation, ammonia toxicity, muscle dysfunction, and disrupted gut-liver-brain axis communication.
Core Pathophysiological Mechanisms
Metabolic and Catabolic Dysfunction
The liver's central role in energy metabolism becomes severely compromised in chronic liver disease. Altered protein metabolism, particularly of branched-chain amino acids (BCAAs), results in reduced circulating BCAA levels, leading to accelerated muscle breakdown and impaired energy generation 1. This creates an imbalance between energy needs and intake, with at least 15% of cirrhotic patients developing hypermetabolism (defined as resting energy expenditure >120% predicted) 1.
Ammonia Toxicity and Muscle Dysfunction
Impaired hepatic ammonia clearance combined with portosystemic shunting increases systemic ammonia concentration, which is directly myotoxic 1. Ammonia causes:
- Decreased protein synthesis in skeletal muscle
- Increased autophagy and proteolysis
- Mitochondrial oxidative dysfunction
- Posttranslational modifications of contractile proteins
- Bioenergetic dysfunction resulting in muscle contractile dysfunction and mass loss 1
This ammonia-mediated muscle dysfunction contributes to both peripheral fatigue (reduced exercise tolerance) and central fatigue through effects on brain neurotransmission 2.
Systemic Inflammation and the Gut-Liver-Brain Axis
Circulating inflammatory markers (IL-1, IL-6, IL-10, C-reactive protein, TNF-α) are elevated in cirrhosis due to increased gut permeability, impaired hepatic clearance of lipopolysaccharide, portosystemic shunting, and gut microbiome alterations 1. This chronic low-grade endotoxemia promotes:
- Reduced muscle protein synthesis
- Increased protein degradation
- Neuroinflammation affecting central nervous system function
- Development of frailty and sarcopenia 1
The gut-brain axis plays a critical role, with microbiome perturbations affecting neural responses and metabolite composition that influence the central nervous system 3.
Endocrine and Hormonal Disruption
Cirrhosis causes reduction in circulating testosterone levels and changes in growth hormone secretion and sensitivity. Low testosterone levels in male cirrhotic patients with sarcopenia contribute to reduced lean body mass and accelerated muscle loss 1. This hormonal disruption further impairs the "liver-muscle axis" mediators.
Complications of Portal Hypertension
Both hepatic encephalopathy (HE) and ascites are strongly associated with fatigue and frailty 1:
- HE causes anorexia, reduced physical activity, and frequent hospitalizations
- Ascites contributes to anorexia, early satiety, increased resting energy expenditure, and limited physical activity
- Increased waist circumference (indicating ascites) is an independent predictor of fatigue severity 4
Central vs. Peripheral Components
Fatigue manifests through both pathways 5, 6:
Central fatigue (brain-mediated):
- Cognitive impairment
- Sleep disturbance
- Apathy and autonomic dysfunction
- Altered neurotransmission within the brain
- Neuroinflammation 2
Peripheral fatigue (neuromuscular):
- Decreased exercise tolerance
- Reduced physical activity levels
- Muscle dysfunction from ammonia toxicity and metabolic derangements
Etiology-Specific Considerations
Different liver disease etiologies show varying fatigue mechanisms 1:
- Alcohol-associated liver disease: Particularly high sarcopenia prevalence (80% in decompensated cirrhosis); alcohol increases muscle autophagy, inhibits proteasome activity, and decreases insulin-like growth factor 1
- NASH/MASLD: Additive effects of insulin resistance and chronic systemic inflammation; metabolic dysregulation and visceral fat accumulation
- Cholestatic diseases: Elevated serum bile acids induce skeletal muscle atrophy through the TGR5 receptor
- Viral hepatitis: Neuropsychiatric symptoms independent of disease severity; viral replication in endothelial cells, astroglia, and microglia causing neuroinflammation
Clinical Predictors
Independent clinical indicators of fatigue severity include 4:
- Increased waist circumference (ascites marker)
- Reduced gait speed
- Lower physical activity levels
Importantly, fatigue is not directly related to the severity of underlying liver fibrosis or dysfunction 5, making it a distinct symptom complex requiring specific attention beyond liver disease staging.
Important Caveats
The pathogenesis remains incompletely understood and is multifactorial 5, 6, 7. Fatigue has strong social/contextual components and is often associated with behavioral alterations including depression and anxiety 7. When evaluating patients with suspected fatigue from liver disease, alternative or additional causes of neuropsychiatric impairment should be identified, as extrahepatic causes (infections, perfusion disorders, subdural hematoma, metabolic derangements) account for 22% of cases in patients with liver disease 8.